Filing
Spy
Filing
Spy
Home
About
KRTX
Karuna Therapeutics Inc
Biopharmaceutical company focused on neurological and psychiatric treatments
CUSIP: 48576A100
Healthcare
US
1 holder
Ownership
Activity
Fundamentals
2020 Q3
14 of 14 quarters
Total Value
$51.33M
Total Shares
663.9K
Net Share Change
+663.9K
Activity
1 buying
Investor
Value
Shares
Weight
Change
Viking Global Investors
$51.33M
663.9K
0.2%
NEW
Viking Global Investors
$51.33M
663.9K shares
NEW
KRTX — Karuna Therapeutics Inc - FilingSpy